Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

Erstveröffentlichung
2019Authors
Ruecker, Frank G.
Agrawal, Mridul
Corbacioglu, Andrea
Weber, Daniela
Kapp-Schwoerer, Silke
Wissenschaftlicher Artikel
Published in
Blood ; 134 (2019), 19. - S. 1608-1618. - ISSN 0006-4971. - eISSN 1528-0020
Link to publication
https://dx.doi.org/10.1182/blood.2019001425Institutions
UKU. Klinik für Innere Medizin IIIDFG Project THU
SFB 1074 / Experimentelle Modelle und klinische Translation bei Leukämien / DFG / 217328187
Subject headings
[Free subject headings]: POLYMERASE-CHAIN-REACTION | TRANS-RETINOIC ACID | PROGNOSTIC IMPACT | RQ-PCR | MUTATIONS | DIAGNOSIS | CANCER | ADULTS | RECOMMENDATIONS | MANAGEMENT[DDC subject group]: DDC 610 / Medicine & health